The efficacy of mindfulness-based cognitive therapy in recurrent depressed patients with and without a current depressive episode: a randomized controlled trial.
Study Goal
The researchers aimed to examine the efficacy of mindfulness-based cognitive therapy (MBCT) in addition to treatment as usual (TAU) for recurrent depressive patients, comparing those with and without a current depressive episode.
Results Summary
MBCT+TAU reduced depressive symptoms, worry, and rumination while increasing mindfulness skills compared to TAU alone. The reduction in depressive symptoms was comparable for patients with and without current depression and was mediated by decreased rumination and worry.
Population
Patients with three or more previous depressive episodes.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
mindfulness-based cognitive therapy (MBCT) in addition to treatment as usual (TAU) | decrease | depressive symptoms | patients with three or more previous depressive episodes | - | reported less | #1 |
mindfulness-based cognitive therapy (MBCT) in addition to treatment as usual (TAU) | decrease | worry | patients with three or more previous depressive episodes | - | reported less | #2 |
mindfulness-based cognitive therapy (MBCT) in addition to treatment as usual (TAU) | decrease | rumination | patients with three or more previous depressive episodes | - | reported less | #3 |
mindfulness-based cognitive therapy (MBCT) in addition to treatment as usual (TAU) | increase | mindfulness skills | patients with three or more previous depressive episodes | - | increased levels | #4 |
MBCT | decrease | depressive symptoms | patients with and without a current depressive episode | - | resulted in a comparable reduction | #5 |
MBCT | decrease | depressive symptoms | patients with recurrent depression | - | reduction | #6 |
BACKGROUND: The aim of this study is to examine the efficacy of mindfulness-based cognitive therapy (MBCT) in addition to treatment as usual (TAU) for recurrent depressive patients with and without a current depressive episode. METHOD: A randomized, controlled trial comparing MBCT+TAU (n=102) with TAU alone (n=103). The study population consisted of patients with three or more previous depressive episodes. Primary outcome measure was post-treatment depressive symptoms according to the Hamilton Rating Scale for Depression. Secondary outcome measures included the Beck Depression Inventory, rumination, worry and mindfulness skills. Group comparisons were carried out with linear mixed modelling, controlling for intra-group correlations. Additional mediation analyses were performed. Comparisons were made between patients with and without a current depressive episode. RESULTS: Patients in the MBCT+TAU group reported less depressive symptoms, worry and rumination and increased levels of mindfulness skills compared with patients receiving TAU alone. MBCT resulted in a comparable reduction of depressive symptoms for patients with and without a current depressive episode. Additional analyses suggest that the reduction of depressive symptoms was mediated by decreased levels of rumination and worry. CONCLUSIONS: The study findings suggest that MBCT is as effective for patients with recurrent depression who are currently depressed as for patients who are in remission. Directions towards a better understanding of the mechanisms of action of MBCT are given, although future research is needed to support these hypotheses.